-

Viz.ai Wins Comparably Awards for Best Place to Work for Second Year

Healthcare AI leader recognized for its outlook and leadership

original Viz.ai Wins Comparably Awards for Best Place to Work for Second Year (Graphic: Business Wire)

Viz.ai Wins Comparably Awards for Best Place to Work for Second Year (Graphic: Business Wire)

SAN FRANCISCO--(BUSINESS WIRE)--Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, has been named a Best Place to Work by Comparably two years in a row. The Company received two Comparably Best Place to Work Awards for Best Company Outlook and Best Leadership Teams in 2023.

“We are honored that Viz.ai has received these two distinguished awards for our outstanding workplace culture. These awards are a reflection of the hard work of our dedicated team and our steadfast commitment to delivering on our mission to increase access to life-saving treatments,” said Dawn Sprague, vice president of people at Viz.ai. “It is our top priority to foster an environment where everyone can thrive and grow, and we continue to invest in a culture that nurtures each individual’s goals and personal growth.”

Comparably recognizes exceptional companies with the Best Place to Work Awards based on anonymous employee ratings about their workplaces over a 12-month period. The final data set was compiled from over 20 million ratings across 70,000 companies.

In 2022, Viz.ai was recognized for Best Company Culture, Best Company for Diversity, Best Company Outlook and Best Company Career Growth.

To learn about opportunities to join Viz.ai, please visit https://www.viz.ai/careers.

About Viz.ai, Inc.

Viz.ai is the pioneer in the use of AI algorithms and machine learning to increase the speed of diagnosis and care, covering more than 220 million lives across 1,400+ hospitals and health systems in the U.S. and Europe. The AI-powered Viz Platform is an intelligent care coordination solution that identifies more patients with a suspected disease, informs critical decisions at the point of care, and optimizes care pathways and helps improve outcomes. Backed by real-world clinical evidence, the Viz Platform delivers significant value to patients, providers, and pharmaceutical and medical device companies. For more information visit viz.ai.

Contacts

Laurie Masonson
laurie.masonson@finnpartners.com

Industry:

Viz.ai, Inc.

Release Versions
English
Hashtags
#ai
#aiinhealthcare
#carecoordination
#partnerships

Contacts

Laurie Masonson
laurie.masonson@finnpartners.com

Social Media Profiles
Viz.ai
Viz.ai
More News From Viz.ai, Inc.

New Data Show Viz.ai’s AI-Enabled ECG Screening Increases Detection and Accelerates Diagnosis of Hypertrophic Cardiomyopathy

SAN FRANCISCO--(BUSINESS WIRE)--Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced new clinical data demonstrating how Viz HCM enables faster, accurate detection of hypertrophic cardiomyopathy (HCM), to help ensure that more patients are identified. Two studies, which will be presented at the American Heart Association (AHA) Scientific Sessions 2025, show Viz.ai’s real-world ability to identify more patients with HCM years earlier than current...

Viz.ai Launches Viz Assist: The First Multimodal AI Agent Platform for Faster Treatment and Better Outcomes

SAN FRANCISCO--(BUSINESS WIRE)--Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced the launch of Viz Assist™, a suite of autonomous AI agents that significantly enhance how care teams identify, prioritize, and act on critical patient data.1 Viz Assist marks a major step forward in Viz.ai’s mission to use technology to reduce time to treatment and improve patient outcomes. Viz Assist incorporates inputs from ambient listening and the electronic...

Viz.ai Launches Viz ACS™ to Accelerate Treatment for Heart Attack and Reduce Unnecessary Activations

SAN FRANCISCO--(BUSINESS WIRE)--Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced the launch of Viz ACS, a new solution in the Viz Cardio™ Suite. Designed to unite the acute coronary syndrome (ACS) care team on a single platform, Viz ACS provides Emergency Department (ED) physicians and cardiologists with the same high-quality ECGs and patient data in real time. This streamlined workflow can help improve communication, speeds treatment, and re...
Back to Newsroom